Oncoinvent reports positive data from phase 1/2a trial of Radspherin in patients with colorectal peritoneal metastases: Oslo, Norway Thursday, June 19, 2025, 11:00 Hrs [IST] Oncoi ...

Camurus announces positive results from POSITANO phase 2b study of octreotide SC depot in patients with symptomatic polycystic liver disease: Lund, Sweden Thursday, June 19, 2025, ...

NEC and Chugai Pharma use AI to potentially enhance cancer treatment: Tokyo Thursday, June 19, 2025, 10:00 Hrs [IST] NEC Corporation, a leader in the integration of IT and network ...

Shardul Nautiyal, Mumbai Thursday, June 19, 2025, 08:00 Hrs [IST] ...

Peethaambaran Kunnathoor, Chennai Thursday, June 19, 2025, 08:00 Hrs [IST] ...

NPPA releases calculation sheet for nine scheduled formulations: Our Bureau, New Delhi Thursday, June 19, 2025, 08:00 Hrs ...

Our Bureau, Mumbai Wednesday, June 18, 2025, 16:30 Hrs [IST] ...

Exports of Drugs and Pharmaceuticals from the country registered around 7.4 per cent growth in the month of May, while imports reported an increase of around 3.04 per cent compared to the same month ...

PCI once again extends timeline for ranking and rating of UG, D Pharm institutes: Gireesh Babu, New Delhi Thursday, June 19, 2025, 08:00 Hrs [IST] The Pharmacy Council of India (P ...

New import rules restricting gold alloyed precious metals may boost pharma imports: Shardul Nautiyal, Mumbai Thursday, June 19, 2025, 08:00 Hrs [IST] In a strategic shift that cou ...

Circle Pharma receives US FDA orphan drug designation for its CID-078 to treat small cell lung cancer: South San Francisco, California Wednesday, June 18, 2025, 18:00 Hrs [IST] So ...

Alcresta Therapeutics begins patient enrollment in clinical trial evaluating use of RELiZORB in critical care patients: Waltham, Massachusetts Wednesday, June 18, 2025, 13:00 Hrs ...